Clearline Capital’s Mereo BioPharma MREO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,834,163
Closed -$7.9M 125
2025
Q3
$7.9M Buy
3,834,163
+216,000
+6% +$398K 0.36% 60
2025
Q2
$9.81M Buy
3,618,163
+400,269
+12% +$966K 0.37% 45
2025
Q1
$7.24M Hold
3,217,894
0.44% 46
2024
Q4
$11.3M Sell
3,217,894
-26,440
-0.8% -$104K 1.49% 20
2024
Q3
$13.3M Sell
3,244,334
-82,384
-2% -$341K 0.57% 32
2024
Q2
$12M Hold
3,326,718
0.33% 29
2024
Q1
$11M Hold
3,326,718
0.54% 31
2023
Q4
$7.68M Buy
3,326,718
+223,995
+7% +$428K 0.47% 41
2023
Q3
$4M Buy
3,102,723
+1,157,683
+60% +$1.54M 0.34% 71
2023
Q2
$2.57M Sell
1,945,040
-107,669
-5% -$125K 0.15% 67
2023
Q1
$1.45M Hold
2,052,709
0.22% 69
2022
Q4
$1.54M Sell
2,052,709
-1,904,426
-48% -$1.56M 0.28% 74
2022
Q3
$3.41M Buy
3,957,135
+898,539
+29% +$1.1M 0.41% 58
2022
Q2
$3.43M Buy
3,058,596
+1,756,813
+135% +$1.36M 0.44% 55
2022
Q1
$1.46M Buy
1,301,783
+615,491
+90% +$796K 0.17% 85
2021
Q4
$1.1M Buy
+686,292
New +$1.37M 0.12% 91

Other funds holding MREO